GZMB and lung cancer: SP1 is a transcription factor overexpressed in lung cancer patients and was predicted to have a binding site with granzyme B. Results showed that the nanoparticles increased the radiosensitivity of lung cancer by reducing cell viability and survival through inhibiting SP1 and upregulating granzyme B [41].